Skip to main content
. 2017 Jan 4;8(7):11249–11258. doi: 10.18632/oncotarget.14497

Figure 3. Comparison of toll-like receptors’ (TLRs) mRNA expressions by GeneChip® human transcriptome array 2.0 between Kawasaki disease patients after IVIG treatment and control subjects.

Figure 3

Asterisks denote significance (p < 0.05). Data are expressed as mean ± standard error for the three replications.